Results 101 to 110 of about 28,240 (212)

Spironolactone for Heart Failure [PDF]

open access: bronze, 2000
Jane M. Geraci, Anne A. Knowlton
openalex   +1 more source

Clinical utility and safety of finerenone in patients with heart failure: Rationale and design of FINE registry

open access: yesESC Heart Failure, Volume 12, Issue 4, Page 3163-3172, August 2025.
Abstract Aims Information about current use of finerenone in patients with heart failure (HF) finerenone in clinical practice is scarce, and its effectiveness in clinical practice in patients is scarce. We aim to assess both the baseline clinical profile and prognostic role of finerenone in patients with HF, irrespective of ejection fraction.
Gonzalo Luis Alonso Salinas   +32 more
wiley   +1 more source

Mineralocorticoid receptor activation contributes to intestinal fibrosis through neutrophil gelatinase-associated lipocalin in preclinical models. [PDF]

open access: yesNat Commun
Amamou A   +17 more
europepmc   +1 more source

Spironolactone

open access: bronze, 1992
F.W. Danby
openalex   +1 more source

Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin‐diabetic rats [PDF]

open access: bronze, 2001
Goran Miric   +5 more
openalex   +1 more source

The Effect of Early Spironolactone Administration on 2-Year Acute Graft Rejection in Cardiac Transplant Patients. [PDF]

open access: yesBiomedicines
Baba DF   +11 more
europepmc   +1 more source

Potential Active Compounds of Ganoderma lucidum and Their Anticancer Effects: A Comprehensive Review

open access: yesFood Science &Nutrition, Volume 13, Issue 8, August 2025.
This paper systematically discusses various active compounds within Ganoderma lucidum and their application in the treatment of tumor diseases. ABSTRACT The incidence and mortality rates of cancer patients continue to rise. Although many physical and chemical therapies, such as targeted tumor treatments, are effective against cancer, they are often ...
Yuan Liu   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy